Accession Number: | 0000899243-21-031258 |
Date: | 2021-07-30 |
Issuer: | SOLENO THERAPEUTICS INC (SLNO) |
Original Submission Date: |
HARRIS WILLIAM G
203 REDWOOD SHORES PKWY, STE 500
REDWOOD CITY, CA 94065
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-07-30 | A | 16,484 | a | $0.00 | 96,032 | direct | ||
COMMON STOCK | 2021-07-30 | F | 5,210 | d | $0.91 | 90,822 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the reported securities are represented by restricted stock units ("rsus"). each rsu represents a contingent right to receive one share of slno common stock. the rsus are fully vested on july 30, 2021. |
f2 | represents shares that have been withheld by the issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the reporting person. |